how to use CASP (Critical Appraisal Skills Programme) RCT Checklist
How to Use the CASP (Critical Appraisal Skills Programme) RCT Checklist
The CASP RCT Checklist is a structured tool to critically appraise Randomized Controlled Trials (RCTs) for validity, reliability, and clinical relevance. It consists of 11 key questions divided into three sections:
- Validity (Are the results trustworthy?)
- Results (What are the findings?)
- Applicability (Can the results be applied to your context?)
🔹 Step 1: Download the CASP RCT Checklist
- Get the free checklist here:
🔗 https://casp-uk.net/casp-tools-checklists/
🔹 Step 2: Appraise the Study Using the 11 Key Questions
A. Validity (Questions 1-6)
1. Did the trial address a clearly focused research question?
- ✔ Look for PICO elements (Population, Intervention, Comparison, Outcome).
- ❌ If the question is vague (e.g., “Does treatment X work?”), it’s a weakness.
2. Was the assignment of participants randomized?
- ✔ Check if randomization was truly random (e.g., computer-generated).
- ❌ If randomization is unclear or not mentioned, downgrade credibility.
3. Were participants and researchers blinded (masked)?
- ✔ Look for double-blinding (participants & assessors unaware of treatment).
- ❌ If blinding was impossible (e.g., surgery vs. drug), note potential bias.
4. Were all participants accounted for at the study’s conclusion?
- ✔ Check attrition/dropout rates (≤20% is acceptable).
- ✔ Was Intention-to-Treat (ITT) analysis used?
- ❌ High dropout (>20%) or per-protocol analysis weakens reliability.
5. Were the groups similar at baseline?
- ✔ Compare baseline characteristics (age, gender, disease severity).
- ❌ Major imbalances suggest flawed randomization.
6. Were participants treated equally apart from the intervention?
- ✔ Check if co-interventions (e.g., additional drugs) were balanced.
- ❌ If one group received extra care, results may be biased.
B. Results (Questions 7-9)
7. How large was the treatment effect?
- ✔ Look for effect size (e.g., Relative Risk, Odds Ratio, Mean Difference).
- ✔ Check confidence intervals (CI)—narrow CIs = more precise results.
8. How precise was the estimate of the treatment effect?
- ✔ If 95% CI crosses “no effect” (RR=1 or MD=0), results may not be significant.
9. Were all important outcomes considered?
- ✔ Check if primary & secondary outcomes were pre-specified.
- ❌ If key outcomes (e.g., side effects) are missing, downgrade quality.
C. Applicability (Questions 10-11)
10. Can the results be applied to your local population?
- ✔ Compare study participants with your patients (age, comorbidities, setting).
- ❌ If the study used highly selected patients, generalizability may be limited.
11. Were all clinically important outcomes considered?
- ✔ Does the study report patient-relevant outcomes (e.g., survival, QoL)?
- ❌ If only surrogate markers (e.g., lab values) are used, clinical relevance is unclear.
🔹 Step 3: Summarize Your Appraisal
After answering all 11 questions, categorize the study as:
✅ High Quality (Mostly “Yes” answers, low risk of bias)
⚠ Moderate Quality (Some “Unclear” or minor flaws)
❌ Low Quality (Multiple “No” answers, high risk of bias)
🔹 Example CASP Appraisal
Question | Answer | Comments |
---|---|---|
1. Focused question? | ✔ Yes | Clear PICO: “Does Drug X reduce mortality in heart failure?” |
2. Randomized? | ✔ Yes | “Computer-generated randomization” |
3. Blinded? | ❌ No | Open-label trial (high risk of bias) |
4. All participants accounted for? | ✔ Yes | 5% dropout, ITT analysis used |
5. Groups similar at baseline? | ✔ Yes | Balanced age, gender, disease severity |
6. Treated equally? | ✔ Yes | No co-interventions reported |
7. Treatment effect size? | ✔ Yes | RR 0.70 (95% CI 0.55–0.89) |
8. Precise estimate? | ✔ Yes | CI does not cross 1 (significant) |
9. All outcomes reported? | ❌ No | Adverse effects missing |
10. Applicable locally? | ⚠ Unclear | Study in Europe; local population differs |
11. Clinically important outcomes? | ✔ Yes | Mortality & hospitalization reported |
Final Rating: ⚠ Moderate Quality (Lack of blinding & missing harms data)
🔹 When to Use CASP RCT Checklist?
✔ Systematic reviews (to assess included studies).
✔ Clinical practice (to decide if evidence is trustworthy).
✔ Journal clubs (teaching critical appraisal skills).
🔹 Comparison with Other Tools
Tool | Best For | Key Difference |
---|---|---|
CASP RCT | Quick, structured appraisal | Focuses on clinical relevance |
Cochrane RoB 2 | Detailed bias assessment | More rigorous for systematic reviews |
SIGN Checklist | Guideline development | Includes study design quality ratings |
Final Tips
✅ Use alongside CONSORT to check reporting completeness.
✅ Involve multiple reviewers to reduce bias in appraisal.
✅ Document justifications for transparency.
Would you like a blank CASP checklist template for your reviews?